PRELUDE CAPITAL MANAGEMENT, LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 126 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$631,000
-49.2%
40,029
-49.8%
0.02%
-56.8%
Q2 2021$1,241,000
-2.7%
79,784
-10.2%
0.04%
+12.1%
Q1 2021$1,276,000
+127500.0%
88,826
+88726.0%
0.03%
Q3 2020$1,000
-98.9%
100
-95.5%
0.00%
-100.0%
Q3 2018$92,000
-58.0%
2,228
-83.2%
0.01%
-75.0%
Q3 2017$219,00013,2250.02%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,610,00011.42%
Redmile Group, LLC 6,048,123$9,737,4780.37%
Baupost Group 9,773,616$15,7360.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 170,000$273,7000.27%
MAVERICK CAPITAL LTD 6,290,713$10,128,0480.22%
683 Capital Management, LLC 1,000,000$1,610,0000.12%
WASATCH ADVISORS LP 8,283,981$13,337,2090.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$845,2500.08%
STALEY CAPITAL ADVISERS INC 750,000$1,207,5000.06%
XTX Topco Ltd 136,841$220,3140.04%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders